|
🐜
|
Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation.
29 auth.
J. Pidala,
Stephanie J. Lee,
K. Ahn,
S. Spellman,
Hai-lin Wang,
M. Aljurf,
M. Askar,
J. Dehn,
M. F. Fernandez Vina,
A. Gratwohl,
Vikas Gupta,
R. Hanna,
M. Horowitz,
C. Hurley,
Y. Inamoto,
...
A. Kassim,
T. Nishihori,
C. Mueller,
M. Oudshoorn,
E. Petersdorf,
V. Prasad,
J. Robinson,
W. Saber,
K. Schultz,
B. Shaw,
J. Storek,
W. Wood,
A. Woolfrey,
C. Anasetti
|
7 |
2014 |
7
🐜
|
|
🐜
|
Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report
42 auth.
A. Tambur,
P. Campbell,
F. Claas,
S. Feng,
H. Gebel,
A. Jackson,
R. Mannon,
E. Reed,
K. Tinckam,
M. Askar,
A. Chandraker,
P. Chang,
Monica M Colvin,
A. Demetris,
J. Diamond,
...
A. Dipchand,
R. Fairchild,
M. Ford,
J. Friedewald,
R. Gill,
D. Glotz,
H. Goldberg,
R. Hachem,
S. Knechtle,
J. Kobashigawa,
D. Levine,
J. Levitsky,
M. Mengel,
E. Milford,
K. Newell,
J. O’Leary,
S. Palmer,
P. Randhawa,
John Smith,
L. Snyder,
R. Starling,
S. Sweet,
T. Taner,
C. Taylor,
S. Woodle,
A. Zeevi,
P. Nickerson
|
7 |
2018 |
7
🐜
|
|
🐜
|
Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus From the Transplantion Society Working Group
26 auth.
C. Schinstock,
R. Mannon,
K. Budde,
A. Chong,
M. Haas,
S. Knechtle,
C. Lefaucheur,
R. Montgomery,
P. Nickerson,
S. Tullius,
C. Ahn,
M. Askar,
M. Crespo,
S. Chadban,
S. Feng,
...
S. Jordan,
K. Man,
M. Mengel,
R. Morris,
Inish O'Doherty,
B. Ozdemir,
D. Serón,
A. Tambur,
K. Tanabe,
J. Taupin,
P. O’Connell
|
7 |
2019 |
7
🐜
|
|
🐢
|
HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ, and HLA-DP.
R. Duquesnoy,
M. Askar
|
7 |
2007 |
7
🐢
|
|
🐜
|
Serum analysis after transplant nephrectomy reveals restricted antibody specificity patterns against structurally defined HLA class I mismatches.
13 auth.
O. Adeyi,
A. Girnita,
J. Howe,
M. Marrari,
Y. Awadalla,
M. Askar,
J. Martell,
A. Zeevi,
R. Shapiro,
M. Nalesnik,
...
P. Randhawa,
A. Demetris,
R. Duquesnoy
|
6 |
2005 |
6
🐜
|
|
🐜
|
The Role of Proteasome Inhibition With Bortezomib in the Treatment of Antibody-Mediated Rejection After Kidney-Only or Kidney-Combined Organ Transplantation
9 auth.
S. Flechner,
R. Fatica,
M. Askar,
B. Stephany,
E. Poggio,
A. Koo,
...
Stacey Banning,
Andres G. Chiesa-Vottero,
T. Srinivas
|
6 |
2010 |
6
🐜
|
|
🐜
|
Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation.
21 auth.
Marcelo Fernandez-Viña,
Tao Wang,
Stephanie J Lee,
M. Haagenson,
M. Aljurf,
M. Askar,
M. Battiwalla,
L. Baxter‐Lowe,
J. Gajewski,
A. Jakubowski,
...
S. Marino,
M. Oudshoorn,
S. Marsh,
E. Petersdorf,
K. Schultz,
E. V. Turner,
Edmund K. Waller,
A. Woolfrey,
J. Umejiego,
S. Spellman,
M. Setterholm
|
6 |
2014 |
6
🐜
|
|
🐜
|
Pre-transplant antibodies to Kα1 tubulin and collagen-V in lung transplantation: clinical correlations.
11 auth.
V. Tiriveedhi,
B. Gautam,
N. Sarma,
M. Askar,
M. Budev,
A. Aloush,
...
R. Hachem,
E. Trulock,
B. Myers,
A. Patterson,
T. Mohanakumar
|
6 |
2013 |
6
🐜
|
|
🐜
|
Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality.
28 auth.
J. Pidala,
Tao Wang,
M. Haagenson,
S. Spellman,
M. Askar,
M. Battiwalla,
L. Baxter‐Lowe,
M. Bitan,
M. Fernández-Viña,
M. Gandhi,
A. Jakubowski,
M. Maiers,
S. Marino,
S. Marsh,
M. Oudshoorn,
...
J. Palmer,
V. Prasad,
V. Reddy,
O. Ringdén,
W. Saber,
S. Santarone,
K. Schultz,
M. Setterholm,
E. Trachtenberg,
E. Turner,
A. Woolfrey,
Stephanie J. Lee,
C. Anasetti
|
6 |
2013 |
6
🐜
|
|
🐬
|
HLAMatchmaker-based analysis of human monoclonal antibody reactivity demonstrates the importance of an additional contact site for specific recognition of triplet-defined epitopes.
R. Duquesnoy,
A. Mulder,
M. Askar,
M. Fernández-Viña,
F. Claas
|
6 |
2005 |
6
🐬
|
